These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9040189)
21. [Adenocarcinoma in Barrett's esophagus. A retrospective study of 46 patients followed during 3.5 years]. Bujanda Fernández de Piérola L; Muñoz Villafranca C; Sánchez Martínez A; Iriondo Martínez de Luco C; Aras Portilla LM An Med Interna; 1999 Apr; 16(4):178-80. PubMed ID: 10339842 [TBL] [Abstract][Full Text] [Related]
22. [Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance]. Zaninotto G; Costantini M; Molena D; Rizzetto C; Ekser B; Ancona E Minerva Chir; 2002 Dec; 57(6):819-36. PubMed ID: 12592224 [TBL] [Abstract][Full Text] [Related]
23. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444 [TBL] [Abstract][Full Text] [Related]
24. Progress in outlining the frequency and risk of recurrent neoplasia after ablation of Barrett's esophagus. Peters JH Gastrointest Endosc; 2010 Apr; 71(4):704-5. PubMed ID: 20363412 [No Abstract] [Full Text] [Related]
25. Barrett's esophagus-is it bad for your health? Falk GW Am J Gastroenterol; 2005 Dec; 100(12):2622-3. PubMed ID: 16393210 [TBL] [Abstract][Full Text] [Related]
26. Screening and surveillance of Barrett's esophagus. Regula J Dig Dis; 2009; 27(1):54-7. PubMed ID: 19439961 [TBL] [Abstract][Full Text] [Related]
27. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma? Quera R; O'Sullivan K; Quigley EM Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424 [TBL] [Abstract][Full Text] [Related]
28. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Conio M; Blanchi S; Lapertosa G; Ferraris R; Sablich R; Marchi S; D'Onofrio V; Lacchin T; Iaquinto G; Missale G; Ravelli P; Cestari R; Benedetti G; Macrì G; Fiocca R; Munizzi F; Filiberti R Am J Gastroenterol; 2003 Sep; 98(9):1931-9. PubMed ID: 14499768 [TBL] [Abstract][Full Text] [Related]
29. Another strike against esophagectomy for high-grade dysplasia in Barrett's esophagus? Wani S; Sharma P Clin Gastroenterol Hepatol; 2008 Feb; 6(2):128-9. PubMed ID: 18237863 [No Abstract] [Full Text] [Related]
30. Barrett's esophagus progressing to cancer: a needle in a haystack? Lewis JJ; Rubenstein JH Clin Gastroenterol Hepatol; 2011 Mar; 9(3):194-5. PubMed ID: 21145422 [No Abstract] [Full Text] [Related]
31. Yield of Higher-Grade Neoplasia in Barrett's Esophagus With Low-Grade Dysplasia Is Double in the First Year Following Diagnosis. Rubenstein JH; Waljee AK; Dwamena B; Bergman J; Vieth M; Wani S Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1529-1530. PubMed ID: 29307847 [No Abstract] [Full Text] [Related]
32. Medical treatment of Barrett's esophagus: can it prevent cancer? Sampliner RE Surg Oncol Clin N Am; 2009 Jul; 18(3):503-8. PubMed ID: 19500739 [TBL] [Abstract][Full Text] [Related]
33. Barrett's esophagus and risk of esophageal adenocarcinoma. Cossentino MJ; Wong RK Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412 [TBL] [Abstract][Full Text] [Related]
34. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma. Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246 [No Abstract] [Full Text] [Related]
35. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Weston AP; Badr AS; Hassanein RS Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296 [TBL] [Abstract][Full Text] [Related]
36. Is the incidence of esophageal adenocarcinomas in patients with Barrett's esophagus really overestimated? Younes M Gastroenterology; 2005 Dec; 129(6):2125-6; author reply 2126. PubMed ID: 16344087 [No Abstract] [Full Text] [Related]
37. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Corey KE; Schmitz SM; Shaheen NJ Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338 [TBL] [Abstract][Full Text] [Related]